Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
IPSS-R: The gold standard for de novo MDS prognostic stratification. Weighted for Cytogenetics, Blasts, and Peripheral Cytopenias.
Cytogenetics
Marrow Blasts (%)
Haemoglobin (g/dL)
Platelets (× 10⁹/L)
ANC (× 10⁹/L)
Total IPSS-R Score
Risk Category
Median Survival: 8.8 yr
Verified
Last Review: 2026
Last Comprehensive Review: 2026
